Want to see IN:METROPOLIS full AI Analyst Report?
Metropolis Healthcare Ltd. (METROPOLIS) Ratios
Metropolis Healthcare Ltd. Ratios
IN:METROPOLIS's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:METROPOLIS's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.40 | 1.18 | 1.28 | 1.14 | 1.30 |
| Quick Ratio | 1.27 | 1.01 | 1.13 | 0.97 | 1.13 |
| Cash Ratio | 0.16 | 0.13 | 0.26 | 0.26 | 0.22 |
| Solvency Ratio | 0.53 | 0.31 | 0.33 | 0.34 | 0.37 |
| Operating Cash Flow Ratio | 1.05 | 0.89 | 1.07 | 0.93 | 0.84 |
| Short-Term Operating Cash Flow Coverage | 18.70 | 29.45 | -17.18 | 4.90 | 2.54 |
| Net Current Asset Value | $ -1.45B | $ -1.87B | $ -1.40B | $ -2.08B | $ -2.49B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.11 | 0.13 | 0.18 | 0.25 |
| Debt-to-Equity Ratio | 0.15 | 0.15 | 0.18 | 0.27 | 0.43 |
| Debt-to-Capital Ratio | 0.13 | 0.13 | 0.15 | 0.21 | 0.30 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.03 | 0.15 |
| Financial Leverage Ratio | 1.41 | 1.40 | 1.42 | 1.52 | 1.73 |
| Debt Service Coverage Ratio | 8.08 | 5.21 | 13.74 | 2.33 | 1.83 |
| Interest Coverage Ratio | 10.88 | 22.45 | 18.25 | 15.51 | 22.52 |
| Debt to Market Cap | 0.00 | 0.00 | -0.00 | 0.01 | 0.02 |
| Interest Debt Per Share | 12.40 | 11.07 | 43.76 | 58.03 | 78.44 |
| Net Debt to EBITDA | 0.42 | 0.76 | 0.62 | 0.84 | 1.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.83% | 77.24% | 77.65% | 76.13% | 75.77% |
| EBIT Margin | 17.24% | 14.70% | 16.16% | 17.74% | 22.93% |
| EBITDA Margin | 25.36% | 16.23% | 18.02% | 20.52% | 24.97% |
| Operating Profit Margin | 16.23% | 40.26% | 42.05% | 42.89% | 45.34% |
| Pretax Profit Margin | 15.75% | 14.34% | 14.46% | 16.33% | 23.88% |
| Net Profit Margin | 11.55% | 10.89% | 10.58% | 12.44% | 17.44% |
| Continuous Operations Profit Margin | 11.62% | 10.93% | 10.64% | 12.49% | 17.48% |
| Net Income Per EBT | 73.32% | 75.96% | 73.17% | 76.20% | 73.01% |
| EBT Per EBIT | 97.02% | 35.61% | 34.39% | 38.08% | 52.67% |
| Return on Assets (ROA) | 8.89% | 7.76% | 8.22% | 9.52% | 14.00% |
| Return on Equity (ROE) | 12.56% | 10.89% | 11.66% | 14.46% | 24.17% |
| Return on Capital Employed (ROCE) | 14.81% | 34.07% | 38.79% | 39.82% | 45.33% |
| Return on Invested Capital (ROIC) | 10.38% | 24.54% | 27.22% | 27.92% | 29.84% |
| Return on Tangible Assets | 20.07% | 18.56% | 17.90% | 21.26% | 29.98% |
| Earnings Yield | 2.12% | 1.85% | 1.43% | 2.23% | 2.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.67 | 9.00 | 9.53 | 9.05 | 8.58 |
| Payables Turnover | 6.63 | 2.41 | 2.71 | 2.91 | 3.30 |
| Inventory Turnover | 18.87 | 6.33 | 6.97 | 6.15 | 5.82 |
| Fixed Asset Turnover | 4.01 | 3.69 | 3.59 | 3.70 | 4.94 |
| Asset Turnover | 0.77 | 0.71 | 0.78 | 0.76 | 0.80 |
| Working Capital Turnover Ratio | 17.68 | 21.90 | 22.42 | 17.76 | 4.95 |
| Cash Conversion Cycle | 2.09 | -53.43 | -43.86 | -25.58 | -5.32 |
| Days of Sales Outstanding | 37.76 | 40.57 | 38.30 | 40.33 | 42.53 |
| Days of Inventory Outstanding | 19.34 | 57.64 | 52.33 | 59.39 | 62.68 |
| Days of Payables Outstanding | 55.02 | 151.63 | 134.49 | 125.30 | 110.53 |
| Operating Cycle | 57.10 | 98.20 | 90.63 | 99.72 | 105.21 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 16.94 | 12.76 | 51.38 | 48.09 | 49.26 |
| Free Cash Flow Per Share | 14.46 | 10.65 | 38.98 | 37.85 | 43.30 |
| Dividend Paid and CapEx Coverage Ratio | 4.87 | 6.05 | 3.13 | 2.64 | 3.54 |
| Capital Expenditure Coverage Ratio | 6.84 | 6.05 | 4.14 | 4.69 | 8.26 |
| Operating Cash Flow Coverage Ratio | 1.51 | 1.29 | 1.34 | 0.93 | 0.67 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.20 | 0.22 | 0.22 | 0.21 |
| Free Cash Flow Yield | 3.33% | 2.79% | 2.24% | 3.03% | 2.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 47.23 | 54.18 | 69.81 | 44.89 | 48.87 |
| Price-to-Sales (P/S) Ratio | 5.45 | 5.90 | 7.39 | 5.59 | 8.52 |
| Price-to-Book (P/B) Ratio | 5.93 | 5.90 | 8.14 | 6.49 | 11.81 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 30.00 | 35.81 | 44.54 | 32.98 | 47.02 |
| Price-to-Operating Cash Flow Ratio | 25.62 | 29.89 | 33.79 | 25.96 | 41.32 |
| Price-to-Earnings Growth (PEG) Ratio | 1.54 | 4.22 | -6.58 | -1.35 | 2.98 |
| Enterprise Value Multiple | 21.92 | 37.11 | 41.62 | 28.06 | 35.14 |
| Enterprise Value | 91.51B | 80.18B | 90.57B | 66.11B | 107.79B |
| EV to EBITDA | 21.92 | 37.11 | 41.62 | 28.06 | 35.14 |
| EV to Sales | 5.56 | 6.02 | 7.50 | 5.76 | 8.78 |
| EV to Free Cash Flow | 30.60 | 36.56 | 45.21 | 34.00 | 48.42 |
| EV to Operating Cash Flow | 26.13 | 30.52 | 34.30 | 26.76 | 42.56 |
| Tangible Book Value Per Share | 16.13 | 12.05 | 50.25 | 31.37 | 14.04 |
| Shareholders’ Equity Per Share | 73.18 | 64.62 | 213.29 | 192.34 | 172.37 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.24 | 0.26 | 0.24 | 0.27 |
| Revenue Per Share | 79.60 | 64.63 | 234.99 | 223.48 | 238.92 |
| Net Income Per Share | 9.19 | 7.04 | 24.87 | 27.81 | 41.66 |
| Tax Burden | 0.73 | 0.76 | 0.73 | 0.76 | 0.73 |
| Interest Burden | 0.91 | 0.98 | 0.90 | 0.92 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.32 | 0.36 | 0.32 | 0.30 | 0.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 |
| Income Quality | 1.84 | 1.81 | 2.07 | 1.32 | 0.86 |
Currency in INR
